Medicare Drug Card Prices Remain High

Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
Report Length
8 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Found Using Methodology
Idependent Author(s)
Brief Executive Summary
The Special Investigations Division of the House Committee on Government Reform examines prices for new Medicare prescription drug cards as published on the Medicare website during the Bush Administration. An analysis found that the initial prices wouldn't provide significant discounts for seniors. The report indicates minimal changes in prices for the least expensive cards, with a 2% increase in the lowest priced card for the ten most popular brand-name drugs used by seniors. Drug card prices also continued to exceed other drug prices, including those negotiated by the federal government and prices in Canada, offering little advantage for seniors.
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views